The Business Research Company’s report goes into great detail on the pulmonary arterial hypertension market size and growth, pulmonary arterial hypertension market regional analysis, pulmonary arterial hypertension market competitive landscape, and other critical information needed to excel in the pulmonary arterial hypertension industry.

Major players in the pulmonary arterial hypertension market include United Therapeutics Corporation, Bayer AG, Gilead Sciences Inc., Johnson & Johnson, GlaxoSmithKline, Pfizer Inc., Sandoz AG, Lupin Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Acceleron Pharma Inc., Eli Lilly and Company, Actelion Pharmaceuticals US Inc, Natco Pharma Ltd, Zydus Pharmaceutical USA, and Liquidia Technologies Inc.

TBRC’s comprehensive market report based on extensive research will assist you in seamlessly devising your approaches in order to match key market player strategies.

The global pulmonary arterial hypertension market is expected to grow from $6.59 billion in 2021 to $7.04 billion in 2022 at a compound annual growth rate (CAGR) of 6.85%. The pulmonary arterial hypertension market is expected to reach $9.65 billion in 2026 at a CAGR of 8.22%.

North America was the largest region in the pulmonary arterial hypertension market in 2021.

The pulmonary arterial hypertension market consists of sales of drugs by entities (organizations, sole proprietors, partnerships) that are used in the treatment of pulmonary arterial hypertension disease, which is a rare progressive disorder characterized by high blood pressure in the arteries of lungs. During this medical condition walls of the pulmonary arteries thicken and stiffen, making it difficult for the blood to flow through the lungs. The pulmonary arterial hypertension drugs relax the muscles in the wall of the blood vessels or increase the blood flow through the lungs or reverse the effect of the substance in the walls of blood vessels, which caused them to narrow.

The increasing prevalence of pulmonary arterial hypertension (PAH) disease is contributing to the growth of the pulmonary arterial hypertension market.

Request a Sample of the Global Pulmonary Arterial Hypertension Market Report

Technological advancements are key trends gaining popularity in the pulmonary arterial hypertension market. The companies operating in the pulmonary arterial hypertension drugs sector are focusing on developing new medicines to improvise and cure the diseases.

TBRC’s Global Pulmonary Arterial Hypertension Market Report Is Segmented:
By Drug Class: Endothelin Receptor Antagonists (ERAs), PDE-5 Inhibitors, Prostacyclin and Prostacyclin Analogs, SGC Stimulators

By Route of Administration: Oral, Intravenous/ subcutaneous, Inhalational

By Distribution channel: Retail, Online

By Geography: North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

The Pulmonary Arterial Hypertension Global Market Report 2022 is one of a series of new reports from The Business Research Company that provides an overview of the pulmonary arterial hypertension market globally and regionally, analyzes and forecasts market size, share, pulmonary arterial hypertension market players, pulmonary arterial hypertension market segments, leading competitor revenues, profiles and market shares.

Here Is A List Of Similar Reports From The Business Research Company:

Anti-Hypertensive Drugs Global Market Report 2022

Wearable Medical Devices Global Market Report 2022

Wearable ECG Monitors Global Market Report 2022

Interested To Know More About The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read More About Us At https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company

Follow us on Twitter: https://twitter.com/tbrc_info

Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: